Ever Source Wealth Advisors, LLC Celldex Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.5 Billion
- Q2 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 407 shares of CLDX stock, worth $13,825. This represents 0.0% of its overall portfolio holdings.
Number of Shares
407
Previous 418
2.63%
Holding current value
$13,825
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$274 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$127 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$115 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$113 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.59B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...